BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9058140)

  • 1. The clinical and histopathological contributing factors influencing the effectiveness of preoperative hyperthermo-chemo-radiotherapy for the patients with esophageal cancer.
    Kitamura M; Sumiyoshi K; Sonoda K; Kitamura K; Tsutsui S; Toh Y; Kuwano H; Sugimachi K
    Hepatogastroenterology; 1997; 44(13):175-80. PubMed ID: 9058140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthermia combined with chemotherapy and irradiation for the prolongation of the postoperative prognosis in the patients with esophageal carcinoma invading neighbouring structures.
    Nozoe T; Kuwano H; Sadanaga N; Watanabe M; Yasuda M; Sugimachi K
    Int Surg; 1996; 81(1):21-6. PubMed ID: 8803700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthermo-chemo-radiotherapy for patients with early carcinoma of the esophagus.
    Matsuda H; Baba K; Kitamura K; Toh Y; Ikeda Y; Sugimachi K
    Hepatogastroenterology; 1993 Jun; 40(3):217-21. PubMed ID: 7686875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical results and prospects of hyperthermia in the treatment of patients with esophageal carcinoma].
    Matsuda H; Sugimachi K; Kuwano H; Mori M; Matsuoka H; Ohno S
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1376-81. PubMed ID: 2454610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinico-pathological studies on the effects of preoperative hyperthermo-chemoradiotherapy of advanced esophageal carcinoma].
    Nakamura T; Ide H; Eguchi R; Nogami A; Endo T; Hanashi T; Kubota N; Hayashi K; Yoshida K; Hanyu F
    Gan To Kagaku Ryoho; 1991 Dec; 18(15):2573-9. PubMed ID: 1720945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multidisciplinary preoperative treatment of esophageal cancer].
    Ikebe M; Kuwano H; Maekawa S; Sugimachi K
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):425-30. PubMed ID: 8129382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term results of preoperative hyperthermo-chemo-radiotherapy (HCR) for patients with esophageal carcinoma invading neighboring structures (T4)].
    Kawaguchi H; Saeki H; Sonoda K; Ohga T; Kitamura K; Nakashima H; Toh Y; Kuwano H; Sugimachi K
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1673-6. PubMed ID: 9382504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of multi-modality treatment for the patients with advanced esophageal cancer].
    Saeki H; Ohga T; Ito S; Futatsugi M; Kimura Y; Kakeji Y; Maehara Y; Nakamura K; Shioyama Y
    Fukuoka Igaku Zasshi; 2002 Dec; 93(12):259-65. PubMed ID: 12632630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multidisciplinary treatment of esophageal cancer].
    Kuwano H; Sadanaga N; Watanabe M; Ikebe M; Mori M; Sugimachi K
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1167-72. PubMed ID: 7687421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthermo-chemo-radiotherapy as a definitive treatment for patients with early esophageal carcinoma.
    Matsuda H; Tsutsui S; Morita M; Baba K; Kitamura K; Kuwano H; Sugimachi K
    Am J Clin Oncol; 1992 Dec; 15(6):509-14. PubMed ID: 1280404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperthermo-chemo-radiotherapy of patients with carcinoma of the esophagus and prediction of the clinical remedial value using the in vitro succinate dehydrogenase inhibition test].
    Matsuda H; Sugimachi K; Ohno S; Mori M; Kuwano H; Maehara Y
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):932-7. PubMed ID: 2730033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperthermia combined with chemotherapy and irradiation for esophageal carcinoma].
    Sugimachi K; Matsufuji H; Kai H; Kitamura M; Maekawa S
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1360-5. PubMed ID: 3729455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
    Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer.
    Nakamura T; Hayashi K; Ota M; Eguchi R; Ide H; Takasaki K; Mitsuhashi N
    Am J Surg; 2004 Sep; 188(3):261-6. PubMed ID: 15450831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Basic and clinical investigations of the effectiveness of hyperthermia combined with chemotherapy and irradiation in the treatment in patients with esophageal carcinoma].
    Kuwano H; Sugimachi K
    Kyobu Geka; 1989 Jul; 42(8 Suppl):677-81. PubMed ID: 2481761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
    Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
    Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiemetic effect of ramosetron during hyperthermo-chemo-radiotherapy for esophageal cancer.
    Morita M; Kuwano H; Ohno S; Kitamura K; Sugimachi K
    Anticancer Res; 2000; 20(5C):3631-6. PubMed ID: 11268430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.